Leucine incoporation in neonatal cardiomyocytes

Reagents:

To measure hypertrophic growth of cardiomyocytes, there are many different approaches including quantification of cell surface area, measuring total protein concentration and RNA concentration. The best and most reliable way is to measure leucine incoporation using radio-labeled 3H-leucine.

1. Day 1, isolate and culture rat neonatal cardiomyocytes.

2. Day 3, starve cardiomyocytes by switching serum-containing medium to serum-free medium.

3. Day 4, start treatment. Dependent on the treatment regime, you may start add 3H-leucine into the medium. I use 1uCi/ml 3H-leucine and use 2 ml medium in each well of 6-well plate.

4. Day 5 or 6, after treatment, when harvesting cells, remove culture medium and wash cells with ice-cold PBS for 3 times. You may need to store all the 3H-leucine containing medium to special containers.

5. Add 2 ml ice-cold 10% TCA in each well and rotate at 4C for 30 min.

6. Remove TCA and wash with ice-cold 95% ethanol for 2 times.

7. Add 1 ml 0.5N NaOH into each well and rotate at 37C to dissolve precipitates for 6 hrs.

8. Add 1 ml 0.5N HCl to neutrolize the solution and transfer all to a scintillation vial.

9. Add 18 ml scintillation cocktail and shake vigorously until the solution becomes clear.

10. Count.


Comments

Add a comment
Site News
New feature:
You can add comments on protocols now. Just go to any individual method page and click on the "Add a comment" link.

Highlight of the month
SIRT6 links glucose and lipid metabolism

SIRT1, a histone deacetylase, has drawn considerable attention due to its important roles in metabolic regulation and longevity. SIRT1 is induced by fasting and suppressed by feeding. SIRT1 increases glucose production and beta oxidation in liver to meet energy needs during food deprivation. Another member of SIRT family, SIRT6 follows similar expression patterns as SIRT1. The function of SIRT6 in metabolic regulation remains unknown.

Kim and colleagues found SIRT1 can regulate SIRT6 expression in liver. Specifically, SIRT1 functions together with FOXO3a and stimulates SIRT6 transcription during fasting. The activation of SIRT6 directly suppresses gene expression of metabolic enzymes involved in triglyceride synthesis and glycolysis in liver. Deficiency of SIRT6 causes increases of glucose utilization, reduced beta oxidation and as a result, fatty liver. More importantly, Kim et al found the expression of SIRT6 is decreased in human fatty liver samples which indicates SIRT6 may play critical roles in liver steatosis in clinical settings. This study landed in Cell Metabolism of this month. ... Read more highlights.